Abstract
Acetarsone, more commonly called stovarsol by the French and Americans and spirocid by the Germans, has been employed in the foreign clinics in the treatment of congenital syphilis since 1924. Numerous reports on the use of this drug have appeared in the foreign literature during the last several years. It has been only within the last year or two that several American clinicians have begun to use acetarsone (stovarsol) in the treatment of congenital syphilis, and it has been only within the last four or five months that the first three reports have appeared in the American literature. Of these three reports, two have come from clinics in Chicago. In these papers the literature is fully reviewed. Acetarsone, chemically known as acetylaminohydroxyphenylarsonic acid, is a white tablet which is odorless and is insoluble in water. It is marketed in 0.1 Gm. and 0.25 Gm. tablets. It contains from 27.1 to
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.